PHEOCHROMOCYTOMA/PARAGANGLIOMA

Clinical trials for PHEOCHROMOCYTOMA/PARAGANGLIOMA explained in plain language.

Never miss a new study

Get alerted when new PHEOCHROMOCYTOMA/PARAGANGLIOMA trials appear

Sign up with your email to follow new studies for PHEOCHROMOCYTOMA/PARAGANGLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 1

New hope for rare tumors? drug axitinib tested in small trial

Disease control Ongoing

This phase II trial tests the drug axitinib in 6 adults with metastatic or inoperable pheochromocytoma or paraganglioma, rare tumors of the adrenal glands or nerve tissue. Axitinib works by blocking blood vessel growth that feeds tumors. The main goal is to see how many patients'…

Matched conditions: PHEOCHROMOCYTOMA/PARAGANGLIOMA

Phase: PHASE2 • Sponsor: Columbia University • Aim: Disease control

Last updated Jun 27, 2026 09:09 UTC

PHEOCHROMOCYTOMA/PARAGANGLIOMA

Get alerted when new PHEOCHROMOCYTOMA/PARAGANGLIOMA trials appear

New hope for rare tumors? drug axitinib tested in small trial